290 results on '"Dunlap, Mark E."'
Search Results
2. Early pandemic in-hospital outcomes and mortality risk factors in COVID-19 solid organ transplant patients
3. Pathophysiology of Cardio-Renal Syndrome: Autonomic Mechanisms
4. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial
5. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry)
6. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial
7. Cardiopulmonary Baroreflex Control of Renal Sympathetic Nerve Activity Is Impaired in Dogs With Left Ventricular Dysfunction
8. Extracardiac Abnormalities of Preload Reserve: Mechanisms Underlying Exercise Limitation in Heart Failure with Preserved Ejection Fraction, Autonomic Dysfunction, and Liver Disease
9. “I've Had a Good Run”
10. Pathophysiology of Cardio-Renal Syndrome: Autonomic Mechanisms
11. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society of Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group
12. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)
13. Autonomic Modulation in Heart Failure: Ready for Prime Time?
14. Autonomic Dysregulation as a Therapeutic Target for Acute HF
15. In-Hospital Resource Use and Medical Costs in the Last Year of Life by Mode of Death (from the HF-ACTION Randomized Controlled Trial)
16. Interactive effects of hypoxia, hypercapnia and lung volume on sympathetic nerve activity in humans
17. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
18. Chemohypersensitivity and Autonomic Modulation of Venous Capacitance in the Pathophysiology of Acute Decompensated Heart Failure
19. Anemia and Iron Deficiency in Heart Failure
20. Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations
21. Evidence for impaired vagus nerve activity in heart failure
22. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure: An Analysis of the CHARM Program
23. Aldosterone antagonists in the treatment and prevention of heart failure
24. Treatment of heart failure with a normal ejection fraction
25. Combination pharmacologic therapies for heart failure: What next after angiotensin-converting enzyme inhibitors and beta-blockers?
26. Management of heart failure with pulmonary hypertension
27. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM)--added trial
28. Is heart failure different on the two continents (North America and Europe)?
29. Prevention of diminished parasympathetic control of the heart in experimental heart failure
30. Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity
31. Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme
32. New Studies Influencing Treatment of Heart Failure: 2006 Update
33. Altered vagal and sympathetic control of heart rate in left ventricular dysfunction and heart failure
34. Cardiorespiratory reflex control in rats with left ventricular dysfunction
35. Activation of cardiac sympathetic afferents: effects of exogenous adenosine and adenosine analogues
36. Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies
37. REFLEXES MEDIATED BY CARDIAC SYMPATHETIC AFFERENTS DURING MYOCARDIAL ISCHAEMIA: ROLE OF ADENOSINE
38. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial
39. A Simplified Technique for the Production of Heart Failure in the Dog by Rapid Ventricular Pacing
40. Heart Failure Patients with Reduced Ejection Fraction Have Higher Prevalence of Cognitive Impairment Despite Normal MMSE
41. Reconsidering Renal Sympathetic Denervation for Heart Failure
42. Impact of Statin Use After Heart Transplantation
43. Measuring Congestion in Acute Heart Failure: The “Holy Grail” Still Awaits
44. Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group
45. Patients With HF Show High Degrees of Moderate to Severe Cognitive Impairment Despite Normal MMSE Testing
46. Adherence to clinical guidelines in heart failure (HF) outpatients: Impact of an interprofessional HF team on evidence-based medication use
47. The role of continuous positive airway pressure in the management of decompensated heart failure complicated by acute pulmonary edema
48. Hospital Management of Hyponatremia in Patients with Heart Failure: Final Report from the HN Registry
49. Heart Failure Notwithstanding Ejection Fraction (HFnEF)—A Possible Unifying Hypothesis?
50. Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.